Grant

Grant - most related articles:

- New hope for hepatitis C sufferers - 2.4
- Low birth weight linked to diabetes gene CDKAL1 - 2.4
- $100000 Grant for innovative global health research - 2.4
- $9 million grant for prostate cancer research - 2.3
- $1 M grants to enhance food and feed safety, US - 2.1
- $5.9 million grant for breast cancer research - 2.1

Grant articles

$3.5 million Komen award to study rare and aggressive type of breast cancer
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.

Immigrant and refugee health guidelines for physicians
The largest, most comprehensive evidence-based guidelines to immigrant health - designed to help Canadian physicians meet the unique needs of this group - are being published in CMAJ (Canadian Medical Association Journal).

Immigrant screening misses majority of imported latent TB
Current UK procedures to screen new immigrants for tuberculosis (TB) fail to detect more than 70 per cent of cases of latent infection, according to a new study published in The Lancet Infectious Diseases.

Victoza, liraglutide approved for type 2 diabetes
Novo Nordisk announced that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.

Coffee ring stain diagnostic test for malaria - Gates Foundation
The US' Gates Foundation funds development of coffee ring stain diagnostic test for malaria. Vanderbilt University received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.

Eurand's Zenpep pancreatic enzyme product approved by FDA
U.S. Food and Drug Administration (FDA) has approved Eurand's New Drug Application (NDA) for ZENPEP(TM) (pancrelipase) Delayed-Release Capsules for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.

GSK's cervical cancer vaccine Cervarix got WHO prequalification
The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline's cervical cancer vaccine. GlaxoSmithKline pharmaceutical company applied for WHO prequalification of Cervarix 2 years ago.

Option Inferior Vena Cava Filter gets FDA clearance in US
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, for use in both permanent and retrievable indications.

Complete response letter for Cinryze for hereditary angioedema
ViroPharma Incorporated (Nasdaq: VPHM) announced that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) related to its supplemental Biologics License Application (sBLA) for Cinryze(TM) (C1 esterase inhibitor [human]) as a treatment for acute attacks of hereditary angioedema (HAE).

$1 M grants to enhance food and feed safety, US
The U.S. Food and Drug Administration recently enhanced its food and feed protection initiatives with the award of three one-year Food Safety and Security Monitoring grants totaling $1 million to the states of Arkansas, Nebraska, and Wisconsin. The funds support cooperative agreements designed to create a national integrated food safety system through enhanced federal and state collaboration in food emergency response activities.

$1.79 billion to help people living with HIV AIDS
The U.S. Department of Health and Human Services (HHS) announced the release of $1.79 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.

Risperdal Consta approved for bipolar disorder
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL® CONSTA® (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.

$5.9 million grant for breast cancer research
Richard Junghans, MD, associate professor of surgery at Boston University School of Medicine (BUSM) and Chief of Surgical Research was named principal investigator of a grant to research how breast cancer patients' own cells can be modified to fight their disease.

Fanapt iloperidone approved for schizophrenia treatment
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced that the US Food and Drug Administration (FDA) has granted marketing approval of Fanapt (iloperidone) for the acute treatment of adult patients with schizophrenia.

Avastin approved for brain cancer Glioblastoma
Genentech, Inc. announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval of Avastin (bevacizumab) for people with glioblastoma with progressive disease following prior therapy.

$100000 Grant for innovative global health research
Vanderbilt University announced that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.

$2.2 million grant to study childhood obesity
In response to a worrisome rise in childhood obesity, Florida school districts have begun to monitor student growth development every year, but there is little research available to determine if the effort is having an effect.

$51 million for cancer research in US
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 143 national research and training grants totaling more than $51 million in the second of two grant cycles for 2009. The grants go into effect beginning July 1, 2009.

Ixiaro to prevent Japanese Encephalitis approved in Europe
Intercell AG (VSE: ICLL) announced that its new vaccine to prevent Japanese Encephalitis, IXIARO, has been approved by the European Commission.

Evolutionary biologist gets grant to study HIV
Dr. Sara Sawyer will use a $120,000 grant from the Foundation for AIDS Research (amFAR) to study how the HIV virus and the cells it attacks have evolved together over time. The goal of her research is to discover new targets for drugs.

Human clinical trial of embryonic stem cell therapy approved
Geron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.

X PRIZE to help fight tuberculosis with Gates Foundation
The X PRIZE Foundation has received a planning grant from the Bill & Melinda Gates Foundation to develop an X PRIZE for effective diagnosis of tuberculosis in the developing world.

$19 Million to M. D. Anderson for breast cancer research
The University of Texas M. D. Anderson Cancer Center has received nearly $19 million in grants from Susan G. Komen for the Cure® as part of that organization's new initiative to fast-track promising research to benefit breast cancer patients.

Foreign PG medical qualifications recognized in India
The Indian Government, exercising powers conferred upon it by the provisions of the Indian Medical Council Act, 1956, has recognized Post Graduate medical qualifications being awarded in Australia, Canada, New Zealand, United Kingdom and United States of America, with the condition that these degrees should be recognized in the respective country for enrolment of medical practitioners in the concerned specialties.

Genentech's Avastin with chemotherapy approved for advanced breast cancer
Genentech, Inc. (NYSE: DNA) announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for Avastin (bevacizumab), in combination with paclitaxel chemotherapy, for the treatment of patients who have not received chemotherapy for their metastatic HER2-negative breast cancer.

$9 million grant for prostate cancer research
Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.

New immigration rules in UK for international medical graduates
The UK Home Office has laid immigration rules that will restrict international medical graduates' (IMGs) access to UK post graduate medical training. The new rules start to take effect from 29 February 2008. New immigration rules were welcomed by the UK Health Secretary Alan Johnson.

27 Grant articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.32